Automated Switching Between Peptide and Glycan Mapping With the Agilent 1290 Infinity II LC System
Glycan and peptide mapping are key analytical methodologies for the structural characterization of therapeutic proteins such as monoclonal antibodies (mAbs), which have emerged as important therapeutics for the treatment of life-threatening diseases including cancer, autoimmune and infectious diseases.
Download this app note to learn more about:
- How to achieve rapid glycan release and labeling
- How to switch between glycan and peptide mapping without manual intervention
- How to provide highly informative and precise data in the analysis of originator and biosimilar mAbs
